KemPharm appoints Tamara A. Seymour to board and audit committee chair

ZEVRA THERAPEUTICS, INC.

Appointment effective August 18, 2021; Seymour becomes Class I director, term expiring at 2022 annual meeting.
Seymour brings over 30 years life sciences experience, including CFO roles at several public and private biotech firms.
Initial grant of 22,500 stock options vesting in three equal annual installments under 2014 equity plan.
Annual retainers: $35,000 for board service and $22,500 for audit committee chair.
CEO notes appointment comes at 'important phase' as KemPharm seeks organic and external growth opportunities.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Tamara A. Seymour

Director and Chair of the Audit Committee

ZVRA · ZEVRA THERAPEUTICS, INC.

Effective: 2021-08-18
Filed: August 18, 2021, 7:59 PM ET

the board of directors (the “Board”) of KemPharm, Inc. (the “Company”) appointed Tamara A. Seymour to serve as a director of the Company and as the chair of the Company’s audit committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tamara A. Seymour was appointed as Director and Chair of the Audit Committee at ZEVRA THERAPEUTICS, INC..

Action: appointed
Role: Director and Chair of the Audit Committee

Exact text from the filing

the board of directors (the “Board”) of KemPharm, Inc. (the “Company”) appointed Tamara A. Seymour to serve as a director of the Company and as the chair of the Company’s audit committee.

View on SEC.gov

ZEVRA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-21-020423

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.